Citadel Advisors’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $265K | Sell |
9,037
-557
| -6% | -$16.3K | ﹤0.01% | 4737 |
|
|
2025
Q1 | $247K | Buy |
+9,594
| New | +$247K | ﹤0.01% | 4676 |
|
|
2024
Q1 | – | Sell |
-83,818
| Closed | -$1.54M | – | 6925 |
|
|
2023
Q4 | $1.54M | Sell |
83,818
-93,676
| -53% | -$1.72M | ﹤0.01% | 2626 |
|
|
2023
Q3 | $3.08M | Buy |
177,494
+5,452
| +3% | +$94.6K | ﹤0.01% | 2003 |
|
|
2023
Q2 | $3.13M | Buy |
172,042
+4,731
| +3% | +$86.1K | ﹤0.01% | 2060 |
|
|
2023
Q1 | $2.87M | Sell |
167,311
-2,748
| -2% | -$47.1K | ﹤0.01% | 2225 |
|
|
2022
Q4 | $3.95M | Sell |
170,059
-11,948
| -7% | -$278K | ﹤0.01% | 1996 |
|
|
2022
Q3 | $4.04M | Sell |
182,007
-6,541
| -3% | -$145K | ﹤0.01% | 2052 |
|
|
2022
Q2 | $3.63M | Buy |
188,548
+9,306
| +5% | +$179K | ﹤0.01% | 2178 |
|
|
2022
Q1 | $6.4M | Buy |
179,242
+1,345
| +0.8% | +$48K | ﹤0.01% | 1847 |
|
|
2021
Q4 | $15.5M | Sell |
177,897
-3,556
| -2% | -$309K | ﹤0.01% | 1105 |
|
|
2021
Q3 | $20.5M | Sell |
181,453
-2,579
| -1% | -$291K | ﹤0.01% | 889 |
|
|
2021
Q2 | $38.9M | Buy |
+184,032
| New | +$38.9M | 0.01% | 605 |
|